P atients with chronic conditions like hypertension may experience many negative emotions which endorse the development of anxiety and depression symptomatology, thus they increase their risk for poor quality of life. Several studies have shown an association between symptoms of psychological distress and hypertension. In this study we aimed to quantify the link between depression, cardiophobia and quality of life in hypertensive patients. A cross-sectional design was employed. A sample of 197 hypertensive patients (89 men-108 women, mean age 53 years, SD=12 ranged 25-78) from a university outpatient hypertension clinic in Greece participated. Ninety-four (47.7%) of the participants suffered from essential grade I hypertension; 68 (34.5%) were grade II; 16 (8.1%) were categorized as grade III, while only 11 (5.6%) patients were recorded as normotensives with high normal values. The questionnaires included: (a) question for the recording of social-demographic characteristics and clinical features, (b) The Short Form (SF-36) Health Survey, (c) The Beck Depression Inventory -I, and (d) The Cardiac Anxiety Questionnaire. There were no significant differences between the two genders with exception of marital status (p=0.010), dyslipidemia (p=0.050), grade of hypertension (p=0.014), cardiac left ventricular hypertrophy (p=0.004), renal failure (p=0.043) and stroke (p=0.024). Lower levels of quality of life and higher levels of depression and cardiophobia were observed compared to the general population. There were no significant differences on psychological measures between the two sexes (p>0.05). Cardiophobia was positively related to depressive symptomatology (r=0.533, p=0.000) while negatively to both
Introduction
Essential hypertension represents a major risk factor for cardiovascular and kidney implications (stroke, coronary artery disease, sudden death, endstage heart and renal failure), 1, 2 causing great burden in health systems worldwide since the prevalence of elevated blood pressure in the general population ranges between 30-45% in various registries. 3, 4 Emerging evidence further supports the negative impact of arterial hypertension in terms of quality of life. 5, 6 Factors leading to this effect have been considered both disease's complications and medication's side effects. 7, 8 In addition, low levels of health-related quality of life (HRQOL) implicate the cardiovascular outcome in this group of patients. 9 Hypertensives tend to demonstrate impaired performance in various dimensions of HRQOL as in general well-being, functional capacity and symptoms of psychological distress. 10, 11 There is also a great consideration regarding the role of psychological factors in the cardiovascular spectrum. [12] [13] [14] [15] Evidence highlights especially the close link between hypertension and depression, which acts in a reciprocal manner. Depressive mood and anxiety have been associated with higher prevalence of hypertension, whereas clinical diagnosis of depression represents a potential risk factor for the development of high arterial blood pressure. [16] [17] [18] Specifically, prospective data show that depressive symptoms enhance the risk of hypertension, 19, 20 while other studies reveal that higher levels of blood pressure (BP) are associated with higher incidence of depression. 21, 22 Patients under medication for hypertension appear to have even 3-times higher possibility to suffer for major depression. 21 Further evidence enlightens the interference of psychological distress (depressive and anxiety symptomatology) in the former association. 16, 17, 19, 23, 24 Patients with uncontrolled high levels of BP tend to demonstrate more stress and depression 24 and otherwise, stress during blood pressure measurements is responsible for white-coat effect as well. 25 Data from the World Mental Health Surveys demonstrate that panic disorder, social phobia and specific phobia were significantly associated with diagnosis of onset hypertension. 26 Some other studies also support that anxiety and depression are strongly correlated with an impaired wellbeing in hypertensive patients. 27 However, the role of heart focused anxiety (HFA i.e. cardiophobia) with respect to essential hypertension has received less attention. Eifert (1992) defined "HFA as a specific fear of cardiac-related stimuli and sensations because of their expected negative consequences". 28 Persons with cardiophobia and elevated HFA focus attention on their heart when experiencing stress and/or arousal and perceive its function as fundamentally dysregulated. 29 Even if some studies revealed that cardiovascular diseases are associated with health anxiety as well as anxious responding to bodily sensations. [30] [31] [32] the identification of cardiophobia as an additional possible factor related to depression and dimensions of HRQOL was not explored in this investigation. Such data merit physical and mental health summary measures of SF-36 health survey (r=-0.467, p=0.000 r=-0.537, p=0.000 respectively). Multiple linear regression models found that for psychical health depression and cardiac anxiety, avoidance activities had an influence on levels of quality of life in hypertensive patients, after controlling for age and other socio-demographic variables and clinical characteristics (Beta=-0.133, p=0.007, Beta=-0.364 p=0.000 and Beta=-0.167 p=0.006, respectively). For mental component summary depression and cardiophobia, heart focused attention had also impact on mental health in hypertensives (Beta=-0.438, p=0.016, Beta=-0.564, p=0.000 and Beta=-0.223, p=0.037, respectively) after adjustments. Heart focused anxiety symptoms-as avoidance activities and/or attention and monitoring cardiac activity, are related to hypertensive patients' present deteriorated depressive symptoms and levels of quality of life. Both depressive symptomatology and heart focused anxiety may be a mechanism partly responsible for hypertensive patients' present impaired levels of quality of life. attention because they give weight to the relevance of screening for cardiac anxiety symptoms in hypertensive patients in order to try to reduce their negative impact on HRQOL. It is a fact that fear of somatic sensations and symptoms appears to be the basis of many clinical syndromes, such as panic disorders, illness phobias, certain specific phobias, somatization, and pain-related disorders. [31] [32] [33] [34] Therefore in this study we aimed to test a theoretical model that explores the hypothesis whether the association between depressive symptoms and domains of quality of life in hypertensive patients was additionally affected by cardiophobia and heart focused anxiety.
Material and method

Subjects and procedures
We prospectively included 197 newly diagnosed patients with essential hypertension. The patients were recruited from the outpatient hypertension clinic at Hippokration University Hospital of Greece. Further inclusion criteria were: age between 18 and 80 years. Patients had not to be under optimized medical therapy for hypertension before entering the study. All patients underwent a detailed clinical work up including a careful medical history further asking for mental disorders, and additional laboratory testing including blood and urine samples in order to evaluate accompanying cardiovascular risk factors and identify primitive implications of hypertension. Cardiac and carotid ultrasounds were implemented in all participants. Diagnosis of hypertension was established combining office and 24-hour ambulatory blood pressure measurements according to 2007 European Society of Hypertension (ESC)/European Society of Cardiology (ESH) guidelines. 35 Exclusion criteria were as follows: having a psychiatrist disorder or being under relevant treatment for such disorder, secondary hypertension, cognitive impairment, and/ or being older than 80 years. All patients gave written informed consent for this study, which was approved by the Ethics Committees of the University of Athens and the Hippokration Hospital. Psychological measures were scored by an expertise psychologist.
Of the 1.307 patients approached during a period of six months, 314 were eligible for inclusion and invited to participate in the study. One hundred and nineteen-seven (62.73%) completed and returned the questionnaires (mean age 53 years, standard deviation SD=12). The rest of them did not complete fully the instruments or did not provide the consent to participate in the study. One hundred-eight (54.8%) patients were females and the rest eighty-nine (45.2%) males. The vast majority of the participants were married (71.1%). The duration of essential hypertension was 27.5 months (SD=40). Ninety-forty of the (47.7%) participants suffered from essential grade I hypertension; 68 (34.5%) were grade II; 16 (8.1%) were categorized as grade III, while only 11 (5.6%) patients were recorded as high normal (normotensives). There were no significant differences between the two genders with exception to marital status (p=0.010), dyslipidemia (p=0.050), grade of hypertension (p=0.014), LV Hypertrophy (p=0.004), renal failure (p=0.043) and stroke (p=0.024). Demographic characteristics of the sample are presented in table 1.
Instruments
Depression
We used the Beck Depression Inventory (BDI-I) 36 in order to measure the depressive symptomatology. The BDI-I is self-report scale consisting of 21-item that assesses cognitive, affective, and somatic depressive symptoms that have occurred over the previous week. This scale although measures depressive symptoms it is not a diagnostic tool to assess major depressive disorder. It has been standardized for the Greek population and has been demonstrated to possess satisfactory psychometric features for clinical and non-clinical samples.
37
Cardiophobia
Heart focused anxiety (commonly referred to as cardiophobia) was measured using the Greek version of Cardiac Anxiety Questionnaire (CAQ). 38 The CAQ consists of 10 items and 3 subscales: (a) Fear (4 items; e.g, "I worry that I may have a heart attack"); (b) Avoidance (3 items; e.g, "I avoid physical exertion"); and (c) Attention (3 items; e.g, "I can feel my heart in my chest."). The CAQ -10 yields a total score and scores for each above subscale. Values close to 4 are representing more anxiety and cardiac functioning concern (i.e. cardiophobia). It has been standardised for the Greek population and found to possess 
Quality of life
Quality of life was measured by using the multipurpose health survey Short Form-36 (SF-36) questionnaire. The SF-36 is a self-reported instrument consisting of only 36 questions. 39 It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical (PSC, physical summary component) and mental health summary measures (MSC, mental summary component) and a preference-based health utility index. The score of each dimension is the addition of the item scores of the related dimension further transformed to a score of 0-100. The higher values representing better perceived health-related quality of life. 39 It is a generic measure, as opposed to one that targets a specific age, disease, or treatment group. It has been standardized for the Greek population and has been demonstrated to possess satisfactory psychometric features for clinical and non-clinical samples. 40 
Demographic characteristics and clinical features
Along with the measures described above the participants completed a questionnaire regarding socio-demographic information (e.g., age, gender, marital status). Clinical information was recorded and evaluated by a specialist cardiologist doctor during a medical interview at hypertensive unit.
Data analysis
Distributions and descriptive statistics were examined for all variables. The criteria for testing normality were: ≥±2.00 for the Skewness and ≥±5.00 for the Kyrtosis. 41 Relations between quality of life scores and depressive symptoms (BDI) scores and between cardiophobia scales and BDI scores were examined by calculating Pearson correlation coefficients. Multivariate analysis of variance was used to examine links between quality of scores and potential confounding variables: age, marital status, etc as well as links among depressive symptoms. Multiple linear regressions analyses were used to test the potential influence of depression and heart focused anxiety scales on quality of life. 
Results
Τable
Correlations among variables
Cross-sectional results showed that cardiophobia (total CAQ) was positively related to depressive symptomatology (r=0.533, p=0.000) while negatively to both physical and mental health summary measures of SF-36 health survey (r=-0.467, p=0.000 r=-0.537, p=0.000 respectively). Furthermore the dimension of Fear was positively related to depressive symptoms (r=0.378, p=.000) while no significant correlation to both physical and mental health summary measures of HRQOL was observed. Therefore this dimension was not included to the final model. Regarding Avoidance was found positively related to depressive symptomatology (r=0.281, p=0.009) while negatively to physical summary measures of SF-36 health survey (r=-0.444, p=0.000) and therefore we included it only to the final model regarding the dimension of Physical Component Summary (PCS). Finally Attention of cardiac activity was found to correlate positively to current level of depression (r=0.366, p=0.005) and negatively to mental health summary component of SF-36 health survey (r=-0.253, p=0.009). As a result we included this dimension of cardiophobia only to the final model regarding the dimension of MCS. The correlations for the psychological variables after controlling for age and gender are presented in table 3.
Potential influence of demographic characteristics and clinical features
Furthermore, in order to clarify the potential influence of demographic and clinical information on the relationship among the two summary components of HRQOL, depressive symptomatology and cardiophobia, we performed multivariate analysis of variance. The results showed significant associations for marital status on MCS SF-36 and, for chronic obstructive pulmonary disease (COPD) on BDI and for the duration of hypertension on PCS. Therefore, these factors were included in the final model testing the role of depression and cardiophobia on quality of life. Detailed associations between variables are presented in table 4. Tables 5 and 6 present the results of two multiple regression models, testing the potential link between depression, cardiophobia and quality of life in hypertensive patients. All analyses were con- ducted separately for physical (PSC) and for mental (MSC) components of SF-36. Though age didn't show significant correlations with regard to multivariate testing, we decided to include this factor in the final regression models as there are relevant published data to support their effect on quality of life. On the whole, multiple regression models found that for psychical health both depression and cardiophobia affect the levels of quality of life in hypertensive patients after controlling for age and other socio-demographic variables (Beta=-0.133, p=0.007, Beta=-0.364, p=0.000 respectively). For mental component summary both depression and cardiophobia had also impact on mental health in hypertensives (Beta=-0.438, p=0.016 and Beta=-0.564, p=0.000) after adjustments. To sum up, adequate associations remain for depression and cardiophobia in both models. 
Testing the impact of depression and cardiophobia on quality of life
Discussion
In this study we explored the possible affecting role of depression and cardiophobia, on HRQOL in essential hypertension era. We found that hypertensive patients demonstrated higher scores in terms of depression and cardiac focus anxiety, whereas presented decreased scores in quality of life, compared to general population. These differences remained significant regardless age, gender variations or other social-demographic and clinical features, which is in contrast with previous published studies. 23, [42] [43] [44] The existing data also indicated the role of duration of hypertension in patient's quality of life, which was a finding recurred in this particular survey. 44, 45 When we performed multiple regression models to test the impact of different factors on HRQOL, depression and cardiophobia were found significantly to affect the quality of life of hypertensive patients.
Our findings are in line with the vast majority of studies punctuate the strong bidirectional link between depression and hypertension. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Most of the dimensions of hypertensive patients' quality of life also were found impaired in our sample as it was expected according to recent evidence. [5] [6] [7] [8] 10, 11 Our study further gives some support on the association between depressive symptoms and general well being, as it is calculated by HRQOL general instruments; 27, 42, 44 We have also showed that in the context of essential hypertension both depressive mood and symptoms of psychological distress, expressed by heart focused anxiety measurements, are responsible for over 50% of the physical component and almost 60% of the mental component of hypertensive patient's feeling of decreased well being. Thus this correlation partly influenced from other social-demographic or clinical determinants, except of marital status and duration of the hypertensive disease. Of course, due to the small impact of beta coefficients, these results must be considered with caution.
We performed a comprehensive clinical and laboratory investigation in our clinical sample, in order to define cardiovascular risk factors, crucial co-morbidities and primary (left ventricular hypertrophy, carotid intima media thickness etc) or established target organ damages (renal/heart failure , stroke etc). Nevertheless, all these factors unexpectedly had a minor and -according to our investigation-non significant contribution to quality of life context. A longitudinal clinical history of hypertension seems solely to affect patient's feeling of inadequate personal health. 44, 45 It is reasonable to assume that a long history of elevated BP simply reinforces the effect of factors of psychological distress. Our data revealed that being in a situation of high BP measurements for a long period of time creates a psychological stressful basis with an effect in patient's life quality. The latter is supported from existing evidence. 46, 47 In this study, we principally aimed to explore the pathway leading from depression and anxiety to quality of life. To be more specific, besides depression and total heart focused anxiety, as for the physical component summary of quality of life, we found that avoidance of actions related to stressed cardiac function i.e. activities elevating BP, heart rate etc. is an extra factor of lower levels of quality of life. On the other hand, as far as for the mental component of quality of life, it seems to be partly influenced especially by attention, which means these patients express a behavior controlled by thorough cardiac monitoring (checking constantly heart pulse, worrying for palpitations, regular BP measurements etc.). We should point out that the former connection acts reciprocally and such distressed behaviors, characterized by factors like attention and avoidance combined with a prolonged history of hypertension further enforce depressive symptomatology. Previous evidence enlightens the link of elevated BP with increased stress and anxiety, in respect with increased sympathetic activity. 13, 48 This study contains some caveats, worthy to refer. First, the cross-sectional design limits any assumption about possible causal associations between the various factors. The selection of the sample further was much dependant to patient's consent to participate in this study. It is plausible to hypothesize those subjects with more prominent symptoms of distress or having great burden of hypertension or accompanying co-morbidities excluded from the final analysis. 43 For instance, the proportion of Grade III hypertension in our sample was small, so the possible effect of more strained clinical syndrome on quality of life may be down-regulated. 44, 45 Moreover, our results were obtained through baseline evaluations during the first visit in an outpatient hypertension clinic. It could be essential to speculate that the observed correlations could be affected in follow-up measurements. However, published data support that these psychological factors demonstrate minor influences even in more prospective approaches. 43 , 45 We performed initial follow up evaluations in a subgroup of our population and we didn't find significant changes during time.* Our research design additionally minimizes the possible effect of other confounding factors as implemented medication. 49, 50 Nevertheless, it could be useful to explore our hypothesis in multiple time points to establish more solid evidence.
To sum up, this study possibly provides a satisfactory explanation of how psychological distress mapping the road from essential hypertension to impaired HRQOL. Taking in consider the limitations, we illustrate a novel insight in the understanding the etiology of hypertension focused on its possible psychosomatic nature, at least for mild grade I and II essential hypertension.
Ασθενείς με χρόνιες καταστάσεις όπως η υπέρταση συχνά βιώνουν αρνητικά συναισθήματα, τα οποία ευνοούν την ανάπτυξη αγχώδους και καταθλιπτικής συμπτωματολογίας και αυξάνουν τον κίνδυνο για επηρεασμένη ποιότητα ζωής. Αρκετές μελέτες υποστηρίζουν αυτή τη συσχέτιση ανάμεσα στις κατα-στάσεις ψυχολογικού στρες και την υπέρταση. Στην παρούσα συγχρονική εργασία επιδιώξαμε να πο-σοτικοποιήσουμε τον σύνδεσμο ανάμεσα στην κατάθλιψη, στην καρδιοφοβία και στην ποιότητα ζωής στους υπερτασικούς ασθενείς. Το δείγμα μας ήταν 197 ασθενείς με ιδιοπαθή υπέρταση (89 άνδρες, 108 γυναίκες, μέση ηλικία 53 χρόνια, σταθερή απόκλιση=12 χρόνια, εύρος 25-78) προερχόμενοι από το αντιυπερτασικό ιατρείο ενός πανεπιστημιακού νοσοκομείου των Αθηνών. Ενενήντα τέσσερεις ασθενείς (47,7%) είχαν υπέρταση σταδίου Ι, 68 (34,5%) είχαν υπέρταση σταδίου II, 16 (8,1%) κατηγοριοποιήθηκαν ως σταδίου III, ενώ μόνο 11 (5,6%) συμμετέχοντες καταγράφηκαν ως νορμοτασικοί με υψηλές φυσιολο-γικές τιμές αρτηριακής πίεσης. Τα εργαλεία που χρησιμοποιήθηκαν ήταν: (α) ερωτηματολόγιο κοινωνι-κο-δημογραφικών χαρακτηριστικών και κλινικών παραμέτρων, (β) η Επισκόπηση Υγείας SF-36, (γ) η Κλίμακα Κατάθλιψης του Beck, και (δ) η Κλίμακα Μέτρησης Άγχους για την Καρδιακή Λειτουργία. Δεν υπήρχαν στατιστικά σημαντικές διαφορές ανάμεσα στα δύο φύλα εκτός από την οικογενειακή κατά-σταση (p=0,010), τη δυσλιπιδαιμία (p=0,050), το στάδιο της υπέρτασης (p=0,014), τον δείκτη υπερτρο-φίας της αριστερής κοιλίας της καρδιάς (p=0,004), τη νεφρική ανεπάρκεια, (p=0,043) και το ιστορικό εγκεφαλικού επεισοδίου (p=0,024). Γενικά παρατηρήθηκαν χαμηλά επίπεδα ποιότητας ζωής και υψη-λά επίπεδα καταθλιπτικής συμπτωματολογίας και καρδιοφοβίας στους ασθενείς με υπέρταση σε σύγ-κριση με τον γενικό πληθυσμό. Η κατά φύλο σύγκριση δεν ανέδειξε στατιστικά σημαντικές διαφορές (p>0,05). Διαπιστώθηκε ότι η καρδιοφοβία σχετίζεται θετικά με την καταθλιπτική συμπτωματολογία (r=0,533, p=0,000) και αρνητικά τόσο με τη σωματική όσο και με την ψυχική διάσταση της Επισκόπησης της Υγείας SF-36 (r=-0,467, p=0,000 r=-0,537, p=0,000 αντιστοίχως). Η ανάλυση πολλαπλής γραμμικής παλινδρόμησης έδειξε ότι η κατάθλιψη, το άγχος για την καρδιακή λειτουργία και οι δραστηριότητες αποφυγής φαίνεται να έχουν επίδραση στα επίπεδα της σωματικής διάστασης της ποιότητας ζωής των υπερτασικών ασθενών, μετά από στάθμιση για τους διάφορους κοινωνικο-δημογραφικούς παράγοντες και κλινικές παραμέτρους (Beta=-0,133, p=0,007, Beta=-0,364 p=0,000 και Beta=-0,167 p=0,006, αντιστοίχως). Από την άλλη πλευρά η κατάθλιψη, η καρδιοφοβία και η επικέντρωση στην καρδιακή λειτουργία είναι οι κύριοι παράγοντες που επηρεάζουν την ψυχική διάσταση της ποιότητας ζωής των υπερτασικών (Beta=-0,438, p=0,016, Beta=-0,564, p=0,000 και Beta=-0,223, p=0,037, αντιστοίχως). Τελικά οι διαστάσεις του άγχους για την καρδιακή λειτουργία, όπως η επικέντρωση στην καρδιακή λειτουργία και η αποφυγή δραστηριοτήτων που δυνητικά την επιβαρύνουν, φαίνεται να σχετίζονται με την καταθλιπτική συμπτωματολογία και τα επίπεδα της ποιότητας ζωής των υπερτασικών ασθενών. Πιθανώς η καταθλιπτική συμπτωματολογία σε συνδυασμό με την καρδιοφοβία να αποτελούν μέρος του μηχανισμού που είναι υπεύθυνος για την επηρεασμένη ποιότητα ζωής στην ιδιοπαθή υπέρταση.
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